Sign In
Buy AMPH
$19.94
-0.440 (-2.16%)
At Close: Jul 31, 2026
Needham Sticks to Its Hold Rating for Clearside Biomedical (CLSD)
09:38am, Thursday, 16'th Apr 2020
Needham analyst Serge Belanger maintained a Hold rating on Clearside Biomedical (CLSD) today. The company's shares closed last Wednesday at $2.41.
Needham Sticks to Its Hold Rating for Clearside Biomedical (CLSD)
09:38am, Thursday, 16'th Apr 2020
Needham analyst Serge Belanger maintained a Hold rating on Clearside Biomedical (CLSD – Research Report) today. The company’s shares closed
Needham Remains a Buy on Verrica Pharmaceuticals (VRCA)
09:38am, Thursday, 16'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Verrica Pharmaceuticals (VRCA) today and set a price target of $20.00. The company's shares
Needham Remains a Buy on Verrica Pharmaceuticals (VRCA)
09:38am, Thursday, 16'th Apr 2020
Needham analyst
Serge Belanger
maintained a
Buy
rating on Verrica Pharmaceuticals (
VRCA
–
Research Report
) today and set a price target of
$20.00
. The company’s shares closed last Wednesday at
Needham Thinks Zynerba Pharmaceuticals' Stock is Going to Recover
09:38am, Thursday, 16'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Zynerba Pharmaceuticals (ZYNE) today and set a price target of $16.00. The company's shares
Needham Thinks Zynerba Pharmaceuticals’ Stock is Going to Recover
09:38am, Thursday, 16'th Apr 2020
Needham analyst
Serge Belanger
maintained a
Buy
rating on Zynerba Pharmaceuticals (
ZYNE
–
Research Report
) today and set a price target of
$16.00
. The company’s shares closed last Wednesday at
BioCryst (BCRX) Gets a Hold Rating from Needham
09:27am, Thursday, 16'th Apr 2020
In a report released today, Serge Belanger from Needham maintained a Hold rating on BioCryst (BCRX). The company's shares closed last Wednesday at $2.70.
Needham Reaffirms Their Buy Rating on KalVista Pharmaceuticals (KALV)
09:27am, Thursday, 16'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on KalVista Pharmaceuticals (KALV) today and set a price target of $28.00. The company's shares
Needham Reaffirms Their Buy Rating on KalVista Pharmaceuticals (KALV)
09:27am, Thursday, 16'th Apr 2020
Needham analyst
Serge Belanger
maintained a
Buy
rating on KalVista Pharmaceuticals (
KALV
–
Research Report
) today and set a price target of
$28.00
. The company’s shares closed last Wednesday at
Liquidia Technologies (LQDA) Receives a Buy from Needham
09:00pm, Wednesday, 15'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Liquidia Technologies (LQDA) today and set a price target of $30.00. The company's shares closed
Liquidia Technologies (LQDA) Receives a Buy from Needham
09:00pm, Wednesday, 15'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Liquidia Technologies (LQDA – Research Report) today and set a price
Needham Keeps Their Buy Rating on Heron Therapeutics (HRTX)
10:38am, Wednesday, 15'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Heron Therapeutics (HRTX) today and set a price target of $44.00. The company's shares closed
Needham Keeps Their Buy Rating on Heron Therapeutics (HRTX)
10:38am, Wednesday, 15'th Apr 2020
Needham analyst
Serge Belanger
maintained a
Buy
rating on Heron Therapeutics (
HRTX
–
Research Report
) today and set a price target of
$44.00
. The company’s shares closed last Tuesday at $14.85.
Flexion Therapeutics (FLXN) Receives a Buy from Needham
10:29am, Wednesday, 15'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Flexion Therapeutics (FLXN) today and set a price target of $36.00. The company's shares closed
Needham Sticks to Its Buy Rating for Revance Therapeutics (RVNC)
10:29am, Wednesday, 15'th Apr 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on Revance Therapeutics (RVNC), with a price target of $36.00. The
